298 related articles for article (PubMed ID: 24077626)
21. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
22. Occult HBV infection in HCC and cirrhotic tissue of HBsAg-negative patients: a virological and clinical study.
Coppola N; Onorato L; Iodice V; Starace M; Minichini C; Farella N; Liorre G; Filippini P; Sagnelli E; de Stefano G
Oncotarget; 2016 Sep; 7(38):62706-62714. PubMed ID: 27486882
[TBL] [Abstract][Full Text] [Related]
23. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
24. Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta-analysis.
Shi Y; Wu YH; Wu W; Zhang WJ; Yang J; Chen Z
Liver Int; 2012 Feb; 32(2):231-40. PubMed ID: 21745272
[TBL] [Abstract][Full Text] [Related]
25. Occult hepatitis B viral DNA in liver carcinomas from a region with a low prevalence of chronic hepatitis B infection.
Kannangai R; Molmenti E; Arrazola L; Klein A; Choti M; Thomas DL; Torbenson M
J Viral Hepat; 2004 Jul; 11(4):297-301. PubMed ID: 15230851
[TBL] [Abstract][Full Text] [Related]
26. Clinical impact of occult HBV infections.
Chemin I; Trépo C
J Clin Virol; 2005 Dec; 34 Suppl 1():S15-21. PubMed ID: 16461218
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues.
Edamoto Y; Tani M; Kurata T; Abe K
Cancer; 1996 May; 77(9):1787-91. PubMed ID: 8646675
[TBL] [Abstract][Full Text] [Related]
28. Occult hepatitis B virus infection and hepatocellular carcinoma: a systematic review.
Huang X; Hollinger FB
J Viral Hepat; 2014 Mar; 21(3):153-62. PubMed ID: 24438677
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection.
Pollicino T; Squadrito G; Cerenzia G; Cacciola I; Raffa G; Craxi A; Farinati F; Missale G; Smedile A; Tiribelli C; Villa E; Raimondo G
Gastroenterology; 2004 Jan; 126(1):102-10. PubMed ID: 14699492
[TBL] [Abstract][Full Text] [Related]
30. Occult hepatitis B infection and hepatocellular carcinoma: Epidemiology, virology, hepatocarcinogenesis and clinical significance.
Mak LY; Wong DK; Pollicino T; Raimondo G; Hollinger FB; Yuen MF
J Hepatol; 2020 Oct; 73(4):952-964. PubMed ID: 32504662
[TBL] [Abstract][Full Text] [Related]
31. Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C.
Kao JH; Chen PJ; Lai MY; Chen DS
J Clin Microbiol; 2002 Nov; 40(11):4068-71. PubMed ID: 12409376
[TBL] [Abstract][Full Text] [Related]
32. Low occurrence of occult hepatitis B virus infection and high frequency of hepatitis C virus genotype 3 in hepatocellular carcinoma in Brazil.
Alencar RS; Gomes MM; Sitnik R; Pinho JR; Malta FM; Mello IM; Mello ES; Bacchella T; Machado MC; Alves VA; Carrilho FJ
Braz J Med Biol Res; 2008 Mar; 41(3):235-40. PubMed ID: 18097499
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of hepatitis C virus infection to alcoholics with cirrhosis in Korea.
Kwon SY; Ahn MS; Chang HJ
J Gastroenterol Hepatol; 2000 Nov; 15(11):1282-6. PubMed ID: 11129222
[TBL] [Abstract][Full Text] [Related]
34. Occult hepatitis B virus infection and its clinical implications.
Hu KQ
J Viral Hepat; 2002 Jul; 9(4):243-57. PubMed ID: 12081601
[TBL] [Abstract][Full Text] [Related]
35. Occult hepatitis B virus and hepatocellular carcinoma.
Pollicino T; Saitta C
World J Gastroenterol; 2014 May; 20(20):5951-61. PubMed ID: 24876718
[TBL] [Abstract][Full Text] [Related]
36. Relative risk of hepatocellular carcinoma in HBsAg positive vs alcoholic cirrhosis. A cross-sectional study.
Hadengue A; N'Dri N; Benhamou JP
Liver; 1990 Jun; 10(3):147-51. PubMed ID: 2166890
[TBL] [Abstract][Full Text] [Related]
37. Occult hepatitis B: the Egyptian situation.
Emara MH
Trop Gastroenterol; 2012; 33(4):242-50. PubMed ID: 23923349
[TBL] [Abstract][Full Text] [Related]
38. Occult hepatitis B virus infection in HBs antigen-negative hepatocellular carcinoma in a Japanese population: involvement of HBx and p53.
Shiota G; Oyama K; Udagawa A; Tanaka K; Nomi T; Kitamura A; Tsutsumi A; Noguchi N; Takano Y; Yashima K; Kishimoto Y; Suou T; Kawasaki H
J Med Virol; 2000 Oct; 62(2):151-8. PubMed ID: 11002243
[TBL] [Abstract][Full Text] [Related]
39. The epidemiology and prevention of hepatocellular carcinoma.
Monto A; Wright TL
Semin Oncol; 2001 Oct; 28(5):441-9. PubMed ID: 11685737
[TBL] [Abstract][Full Text] [Related]
40. [Hepatocellular carcinoma, hepatitis B virus and the immune system].
Grob PJ
Schweiz Med Wochenschr; 1986 Aug; 116(34):1133-45. PubMed ID: 3020684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
